
Given subcutaneously every 3 months, cemdisiran (Livsayis) is indicated for adults with AChR antibody–positive gMG and requires REMS enrollment.
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses how providers can improve patient care through collaboration.
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses how providers can improve patient care through collaboration.